Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Zehender

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 26, 2023
Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2Federica Giannetti, Miriam Barbieri, Assad Shiti, et al.
European Heart Journal|November 30, 2018
Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibilityKatja E Odening, Ilona Bodi, Gerlind Franke, et al.
European Heart Journal|August 8, 2024
KCNQ1 suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndromeSahej Bains, Lucilla Giammarino, Saranda Nimani, et al.
European Heart Journal|August 30, 2025
AAV9-mediated KCNH2 suppression-replacement gene therapy in a transgenic rabbit model of type 1 short QT syndromeSaranda Nimani, Sahej Bains, Nicolò Alerni, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 26, 2023
Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2Federica Giannetti, Miriam Barbieri, Assad Shiti, et al.
European Heart Journal|November 30, 2018
Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibilityKatja E Odening, Ilona Bodi, Gerlind Franke, et al.
European Heart Journal|August 8, 2024
KCNQ1 suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndromeSahej Bains, Lucilla Giammarino, Saranda Nimani, et al.
European Heart Journal|August 30, 2025
AAV9-mediated KCNH2 suppression-replacement gene therapy in a transgenic rabbit model of type 1 short QT syndromeSaranda Nimani, Sahej Bains, Nicolò Alerni, et al.
Pageof 11